Today: May 25, 2018, 10:58 am
  
Business

Oxford Immunotec to Present at the 2018 UBS Global Healthcare Conference

PR-Inside.com: 2018-05-16 15:04:01

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the 2018 UBS Global Healthcare Conference on Wednesday, May 23, 2018, at 9:30 a.m. ET.  The conference will be held at the Grand Hyatt Hotel in New York.

About Oxford Immunotec

Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions.  The Company's first product is the T-SPOT®.TB test, which is used to test for tuberculosis infection.  The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China.  The Company's second product line is a range of assays for tick-borne diseases, such as Lyme disease. The Company is headquartered near Oxford, U.K. and in Marlborough, Mass.  Additional information can be found at www.oxfordimmunotec.com.

T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.  Immunetics is a trademark of Immunetics, Inc.

CONTACT:

For Media and Investor Inquiries: 
Karen Koski
Head of Strategy and Investor Relations
Oxford Immunotec
Tel: +1 (508) 556-1377
kkoski@oxfordimmunotec.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Oxford Immunotec via Globenewswire




# 393 Words
Related Articles
More From The Author
Duo Security's Zero-Trust Platform Delivers Agentless BYOD [..]
The solution eliminates the need for traditional mobile device management (MDM) and significantly improves security for organizations [..]
Nomura Research Institute Recognized for Work in [..]
Nomura Research Institute (NRI, TOKYO:4307), a leading provider of consulting services and system solutions, were recognized during [..]
Press Invitation from Finland Chamber of Commerce [..]
Helsinki International Arbitration Day 2018 ( www.hiad.fi : The speakers include highly distinguished international arbitration practitioners. [..]
KONE wins first KONE UltraRope® order in [..]
KONE Corporation, press release, May 16, 2018   KONE, a global leader in the elevator and escalator industry, has won [..]
THE FIRST GROUP Teams With IQI Global [..]
The First Group : This press release features multimedia. View the full release here. Rob Burns, The First Group’s Chief [..]
 
More From Business
G2H2 Capital Makes a Purchase on the [..]
HONG KONG, May 24, 2018 - (ACN Newswire) - G2H2 Capital ("G2H2") signed an agreement with AnApp Blockchain Technologies Limited [..]
Oppenheimer Europe CEO Max Lami On Course [..]
Oppenheimer Europe CEO Max Lami On Course With M&A Business Expansion Plan, Four Years On Nearly four years have passed [..]
AnApp announces the birth of an innovative [..]
HONG KONG, May 21, 2018 - (ACN Newswire) - AnApp Blockchain Technologies Limited ("AnApp") announces the development of [..]
HKTDC Entrepreneur Day 2018 Opens
Most International and Tech-focused Edition Ever HONG KONG, May 17, 2018 - (ACN Newswire) - A record 276 exhibitors are [..]
Stripe and JCB Sign MOU for Global [..]
Enabling JCB brand payment at merchants around the world using the Stripe payment platform San Francisco and Tokyo, May 17, [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.